Table II.
Genotypes of the XRCC1 and XPD genes in the hepatocellular carcinoma and control groups.
| Genotype | Hepatocellular carcinoma group | Control group | OR (95% CI) | P-values |
|---|---|---|---|---|
| XPD 312 | ||||
| GG | 192 | 207 | 1.00 | 0.08 |
| GA + AA | 60 | 43 | 1.56 (1.02–2.22) | |
| AA | 2 | 1 | ||
| G (Asp) frequency | 85.7% | 91.2% | ||
| A (Asn) frequency | 14.3% | 8.8% | ||
| XRCC1 280 | ||||
| GG | 193 | 206 | 1.00 | 0.12 |
| GA + AA | 59 | 44 | 1.43 (0.97–2.10) | |
| AA | 6 | 5 | ||
| G (Arg) frequency | 87.1% | 90.2% | ||
| A (His) frequency | 12.9% | 9.8% | ||
| XRCC1 194 | ||||
| CC | 119 | 128 | 1.00 | 0.42 |
| CT + TT | 133 | 122 | 1.17 (0.87–1.59) | |
| TT | 18 | 21 | ||
| C (Arg) frequency | 70.0% | 71.4% | ||
| T (Trp) frequency | 30.0% | 28.6% |